Loading clinical trials...
Loading clinical trials...
Phase II Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-angiogenic Approach
Conditions
Interventions
Vincristine
VP-16
+3 more
Locations
1
United States
University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
Start Date
October 1, 2004
Primary Completion Date
November 1, 2008
Completion Date
May 1, 2014
Last Updated
August 3, 2015
NCT04704661
NCT05198830
NCT06842498
NCT05372640
NCT03191149
NCT05692635
Lead Sponsor
New Mexico Cancer Research Alliance
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions